Restricted accessResearch articleFirst published online 2026
Nurses’ Plans and Actions to Advocate for Legislation to Phase Out Use of Select Di(2-Ethylhexyl) Phthalate Plastic Supplies in Health Services Delivery in North Carolina
Nurses have professional responsibilities to advocate for environmentally healthy practices and have rights to work in healthy environments. Many medical supplies are made with polyvinyl chloride, which is softened and made more flexible by adding phthalates, such as di(2-ethylhexyl) phthalate (DEHP). Patients, nurses, and other health workers are exposed to these toxins through dermal, inhalation, ingestion, and/or parenteral administration. Phthalates are classified as carcinogenic, mutagenic, reprotoxic, and endocrine-disruptors.
Purpose
The purpose of our project is to develop a nurse-led advocacy plan focused on drafting, introducing, and passing a bill banning use of medical supplies made with DEHP and related plasticizers in North Carolina (NC) health systems and engaging nurses and other stakeholders in advocating for this policy change to protect the health of patients, employees, and the planet.
Advocacy Plan
We developed a health policy advocacy plan describing the issue; goal; interest groups; partners; scientific evidence; advocacy strategies; and expected outcomes. We engaged our project partners in implementing successful advocacy efforts. On March 31, 2025, NC House Bill 592, Toxic-Free Medical Devices Act of 2025, was introduced in the NC General Assembly. The Senate version was signed into law on July 3, 2025.
Discussion
Nurses are well-positioned to advocate for policies that protect health by addressing primary drivers of health, including environmental risk factors. Our nurse-led health policy advocacy plan and actions supported the development and passing of a bill that protects patients and health services workers from DEHP and other toxic plasticizers linked to numerous health problems.
American Nurses Association. (2007). ANA’s principles of environmental health for nursing practice with implementation strategies. American Nurses Association, Silver Spring, MD.
4.
American Nurses Association. (2010). Nursing: Scope and standards of practice (2nd ed.). American Nurses Association, Silver Spring, MD.
Baxter. (n.d). Baxter U.S. non-DEHP product overview [PowerPoint slides].
10.
Baxter Healthcare. (2025, March 2). Product catalog. file:///C:/Users/jvann/Downloads/product-list.pdf.
11.
BernardL.MasseM.BoeufB.ChennellP.DecaudinB.DurandN.GenayS.LambertC.Le BasleY.MoreauE.PinguetJ.PonsonnailleV.RichardD.SaturninN.StormeL.SautouV. (2023). Medical devices used in NICU: The main source of plasticisers’ exposure of newborns. The Science of the Total Environment, 858(Pt 3), Article 159994. https://doi.org/10.1016/j.scitotenv.2022.159994
BraunJ. M.SathyanarayanaS.HauserR. (2013). Phthalate exposure and children's health. Current Opinion in Pediatrics, 25(2), 247–254. https://doi.org/10.1097/MOP.0b013e32835e1eb6
CalafatA. M.NeedhamL. L.SilvaM. J.LambertG. (2004). Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics, 113(5), e429–e434. https://doi.org/10.1542/peds.113.5.e429
ChielliniF.FerriM.LatiniG. (2011). Physical-chemical assessment of di-(2-ethylhexyl)-phthalate leakage from poly(vinyl chloride) endotracheal tubes after application in high risk newborns. International Journal of Pharmaceutics, 409(1-2), 57–61. https://doi.org/10.1016/j.ijpharm.2011.02.024
21.
ChiuP.CummingsG. G.ThorneS.Schick-MakaroffK. (2021). Policy advocacy and nursing organizations: A scoping review. Policy, Politics & Nursing Practice, 22(4), 271–291. https://doi.org/10.1177/15271544211050611
22.
EckertE.KuhlmannL.GöenT.MünchF. (2023). Assessment of the plasticizer exposure of hospital workers regularly handling medical devices: A pilot study. Environmental Research, 237(Pt 2), Article 117028. https://doi.org/10.1016/j.envres.2023.117028
23.
ElliottR. S. (2025). Every nurse can become an advocate: Pathways for meaningful policy change. Journal of Radiology Nursing, 44(1), 36–39. https://doi.org/10.1016/j.jradnu.2024.10.004
24.
EtowaJ.VukicA.AstonM.IduyeD.MckibbonS.GeorgeA.NkwochaC.ThapaB.AbrhaG.DolJ. (2023). Experiences of nurses and midwives in policy development in low- and middle-income countries: Qualitative systematic review. International Journal of Nursing Studies Advances, 5, Article 100116. https://doi.org/10.1016/j.ijnsa.2022.100116
25.
EtzelR. A. (2020). The special vulnerability of children. International Journal of Hygiene and Environmental Health, 227, Article 113516. https://doi.org/10.1016/j.ijheh.2020.113516
General Assembly of North Carolina. (2025a, April 1). Session 2025. House bill 592. Toxic free medical devices act of 2025. An act to prohibit the manufacturing, selling, and distributing intravenous solution containers and intravenous tubing that are intentionally made with DEHP.https://www.ncleg.gov/Sessions/2025/Bills/House/PDF/H592v1.pdf
HajizadehA.ZamanzadehV.KakemamE.BahreiniR.Khodayari-ZarnaqR. (2021). Factors influencing nurses participation in the health policy-making process: A systematic review. BMC nursing, 20(1), Article 128. https://doi.org/10.1186/s12912-021-00648-6
33.
HanN. K.KimG. S. (2024). The barriers and facilitators influencing nurses’ political participation or healthcare policy intervention: A systematic review and qualitative meta-synthesis. Journal of Nursing Management, 2024, Article 2606855. https://doi.org/10.1155/2024/2606855
JamaraniR.ErythropelH. C.NicellJ. A.LeaskR. L.MarićM. (2018). How green is your plasticizer?Polymers, 10(8), Article 834. https://doi.org/10.3390/polym10080834
42.
JenkinsR.OnduskoD.MontroseL.ForbushR.RozanskyD. (2021). Phthalate exposures in the neonatal intensive care unit. Toxics, 9(5), Article 90. https://doi.org/10.3390/toxics9050090
KochH. M.PreussR.AngererJ. (2006). Di(2-ethylhexyl)phthalate (DEHP): Human metabolism and internal exposure–an update and latest results. International Journal of Andrology, 29(1), 155–185. https://doi.org/10.1111/j.1365-2605.2005.00607.x
45.
KolenaB.HlisníkováH.KečkéšovἊidlovskáM.TrnovecT.PetrovičováI. (2022). Risk of abdominal obesity associated with phthalate exposure of nurses. Toxics, 10(3), Article 143. https://doi.org/10.3390/toxics10030143
46.
LatiniG.FerriM.ChielliniF. (2010). Materials degradation in PVC medical devices, DEHP leaching and neonatal outcomes. Current Medicinal Chemistry, 17(26), 2979–2989. https://doi.org/10.2174/092986710792064992
LiX.XiaoC.LiuJ.WeiN.SongJ.YuanJ.LiuL.SongR.YiW.PanR.ChengJ.WangS.SuH. (2024). Association of di(2-ethylhexyl) phthalate exposure with reproductive hormones in the general population and the susceptible population: A systematic review and meta-analysis. Environment & Health, 2(11), 750–765. https://doi.org/10.1021/envhealth.4c00046
MatisāneL.KnudsenL. E.Lobo VicenteJ.UhlM.KatsonouriA.van den BrandA. D.BermanT.DimovskaM.AnastasiE.ThomaA.KözépesyS.GjorgjevD.Borota PopovskaM.den Braver-SewradjS. P.SzigetiT.Topuzovska LatkovikjM.MārtiņsoneI.AkūlovaL.PaegleL. (2022). Citizens’ perception and concerns on chemical exposures and human biomonitoring-results from a harmonized qualitative study in seven European countries. International Journal of Environmental Research and Public Health, 19(11), Article 6414. https://doi.org/10.3390/ijerph19116414
51.
MoshkbidE.CreeD. E.BradfordL.ZhangW. (2024). Biodegradable alternatives to plastic in medical equipment: Current state, challenges, and the future. Journal of Composites Science, 8(9), Article 342. https://doi.org/10.3390/jcs8090342
National Toxicology Program. (2021, December 21). 15th report on carcinogens: Di(2-ethylhexyl) phthalate (CAS No. 117-81-7). National Institute of Environmental Health Sciences. Research Triangle Park, NC. https://www.ncbi.nlm.nih.gov/books/NBK590781/
RudénC.HanssonS. O. (2010). Registration, evaluation, and authorization of chemicals (REACH) is but the first step-how far will it take us? Six further steps to improve the European chemicals legislation. Environmental Health Perspectives, 118(1), 6–10. https://doi.org/10.1289/ehp.0901157
ŠimunovićA.TomićS.KranjčecK. (2022). Medical devices as a source of phthalate exposure: A review of current knowledge and alternative solutions. Arhiv za Higijenu Rada I Toksikologiju, 73(3), 179–190. https://doi.org/10.2478/aiht-2022-73-3639
StroustrupA.BraggJ. B.AndraS. S.CurtinP. C.SpearE. A.SisonD. B.JustA. C.AroraM.GenningsC. (2018). Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance. PloS One, 13(3), Article e0193835. https://doi.org/10.1371/journal.pone.0193835
67.
StroustrupA.BraggJ. B.BusgangS. A.AndraS. S.CurtinP.SpearE. A.JustA. C.AroraM.GenningsC. (2020). Sources of clinically significant neonatal intensive care unit phthalate exposure. Journal of Exposure Science & Environmental Epidemiology, 30(1), 137–148. https://doi.org/10.1038/s41370-018-0069-2
68.
SwiftL. M.RobertsA.PressmanJ.GuerrelliD.AllenS.HaqK. T.ReiszJ. A.D'AlessandroA.PosnackN. G. (2024). Evidence for the cardiodepressive effects of the plasticizer di-2-ethylhexyl phthalate. Toxicological Sciences, 197(1), 79–94. https://doi.org/10.1093/toxsci/kfad105
The Medical Society Consortium on Climate and Health. (n.d.). About us. Climate change is one of the most important issues of our time and has major health and healthcare implications. George Mason University Center for Climate Change Communication. https://medsocietiesforclimatehealth.org/about/
Van VlietE. D.ReitanoE. M.ChhabraJ. S.BergenG. P.WhyattR. M. (2011). A review of alternatives to di (2-ethylhexyl) phthalate-containing medical devices in the neonatal intensive care unit. Journal of Perinatology, 31(8), 551–560. https://doi.org/10.1038/jp.2010.208
77.
WangW.KannanK. (2023). Leaching of phthalates from medical supplies and their implications for exposure. Environmental Science & Technology, 57(20), 7675–7683. https://doi.org/10.1021/acs.est.2c09182
WeeS. Y.ArisA. Z.YusoffF. M.PraveenaS. M. (2024). Public perception on human exposure risk: A case study on endocrine disrupting compounds in the environment. Ecotoxicology and Environmental Safety, 270, Article 115830. https://doi.org/10.1016/j.ecoenv.2023.115830
80.
WeuveJ.SánchezB. N.CalafatA. M.SchettlerT.GreenR. A.HuH.HauserR. (2006). Exposure to phthalates in neonatal intensive care unit infants: Urinary concentrations of monoesters and oxidative metabolites. Environmental Health Perspectives, 114(9), 1424–1431. https://doi.org/10.1289/ehp.8926
81.
WilliamsE. S.PankoJ.PaustenbachD. J. (2009). The European Union's REACH regulation: A review of its history and requirements. Critical Reviews in Toxicology, 39(7), 553–575. https://doi.org/10.1080/10408440903036056
82.
WuQ.LiG.ZhaoC. Y.NaX. L.ZhangY. B. (2023). Association between phthalate exposure and obesity risk: A meta-analysis of observational studies. Environmental Toxicology and Pharmacology, 102, Article 104240. https://doi.org/10.1016/j.etap.2023.104240
83.
YangL.LiuX.PengZ.LiuZ.SongP.ZhouJ.MaK.YuY.DongQ. (2024). Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer. BMC Public Health, 24(1), Article 430. https://doi.org/10.1186/s12889-024-17801-w
ZengF.ZhangL.DengF.LouS. (2023). Early-life exposure to di (2-ethyl-hexyl) phthalate: Role in children with endocrine disorders. Frontiers in Cell and Developmental Biology, 11, Article 1115229. https://doi.org/10.3389/fcell.2023.1115229
